Bioethics News

States Move to Give Terminally Ill ‘Right-to-Try’ Drugs

(USA Today) – A growing number of states are considering legislation to allow terminally ill patients to gain access to experimental drugs, before the U.S. Food and Drug Administration deems them market-ready. “Right-to-try” laws were passed in five states last year — Arizona, Colorado, Louisiana, Michigan and Missouri, according to the National Conference of State Legislatures. Twenty-five more have proposed similar legislation.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.